carbachol has been researched along with Libman-Sacks Disease in 1 studies
Carbachol: A slowly hydrolyzed CHOLINERGIC AGONIST that acts at both MUSCARINIC RECEPTORS and NICOTINIC RECEPTORS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Waterman, SA | 1 |
| Gordon, TP | 1 |
| Rischmueller, M | 1 |
1 other study available for carbachol and Libman-Sacks Disease
| Article | Year |
|---|---|
Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjögren's syndrome.
Topics: Acetylcholine; Adult; Aged; Aged, 80 and over; Animals; Autoantibodies; Carbachol; Female; Humans; I | 2000 |